Effects of Infantile Hypophosphatasia on Human Dental Tissue

Calcif Tissue Int. 2023 Mar;112(3):308-319. doi: 10.1007/s00223-022-01041-4. Epub 2022 Nov 21.

Abstract

Hypophosphatasia (HPP) is an inherited, systemic disorder, caused by loss-of-function variants of the ALPL gene encoding the enzyme tissue non-specific alkaline phosphatase (TNSALP). HPP is characterized by low serum TNSALP concentrations associated with defective bone mineralization and increased fracture risk. Dental manifestations have been reported as the exclusive feature (odontohypophosphatasia) and in combination with skeletal complications. Enzyme replacement therapy (asfotase alfa) has been shown to improve respiratory insufficiency and skeletal complications in HPP patients, while its effects on dental status have been understudied to date. In this study, quantitative backscattered electron imaging (qBEI) and histological analysis were performed on teeth from two patients with infantile HPP before and during asfotase alfa treatment and compared to matched healthy control teeth. qBEI and histological methods revealed varying mineralization patterns in cementum and dentin with lower mineralization in HPP. Furthermore, a significantly higher repair cementum thickness was observed in HPP compared to control teeth. Comparison before and during treatment showed minor improvements in mineralization and histological parameters in the patient when normalized to matched control teeth. HPP induces heterogeneous effects on mineralization and morphology of the dental status. Short treatment with asfotase alfa slightly affects mineralization in cementum and dentin. Despite HPP being a rare disease, its mild form occurs at higher prevalence. This study is of high clinical relevance as it expands our knowledge of HPP and dental involvement. Furthermore, it contributes to the understanding of dental tissue treatment, which has hardly been studied so far.

Keywords: ALPL; Enzyme replacement therapy; HPP; TNSALP; Tooth.

MeSH terms

  • Alkaline Phosphatase / genetics
  • Calcification, Physiologic
  • Calcinosis* / complications
  • Humans
  • Hypophosphatasia* / complications
  • Tooth Demineralization* / complications
  • Tooth Demineralization* / drug therapy

Substances

  • Alkaline Phosphatase

Supplementary concepts

  • Hypophosphatasia, Infantile